--- title: "Firefly Neuroscience, Inc. (AIFF.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/AIFF.US.md" symbol: "AIFF.US" name: "Firefly Neuroscience, Inc." industry: "医疗信息服务" --- # Firefly Neuroscience, Inc. (AIFF.US) | Item | Detail | |------|--------| | Industry | 医疗信息服务 | | Location | 美股市场 | | Website | [fireflyneuro.com](https://fireflyneuro.com) | ## Company Profile Firefly Neuroscience, Inc.是一家医疗技术和人工智能公司,提供神经科学解决方案,以改善精神疾病和神经系统疾病患者的脑健康结果。该公司提供脑网络分析(Brain Network Analytics)软件,专注于对精神疾病和认知障碍患者的诊断和治疗,包括抑郁症、痴呆症、焦虑症、脑震荡和注意力缺陷/多动症。它为制药公司和医疗从业者提供服务。Firefly Neuroscience, Inc ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:12.000Z **Overall: C (0.48)** **Industry**: Health Care Technology | Metric | Value | |--------|-------| | Industry Ranking | 26 / 47 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 958.11% | | | Net Profit YoY | -230.20% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 1.03 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 9.92M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 783000.00 | | **Multi Score**: C #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -411.76% | E | | Profit Margin | -2705.87% | E | | Gross Margin | 37.63% | B | #### Growth Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 958.11% | A | | Net Profit YoY | -230.20% | E | | Total Assets YoY | 133.61% | A | | Net Assets YoY | 247.87% | A | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -3.06% | D | | OCF YoY | 958.11% | A | #### Operating Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.09 | E | #### Debt Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 22.16% | A | ```chart-data:radar { "title": "Longbridge Financial Score - Firefly Neuroscience, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-411.76%", "rating": "E" }, { "name": "Profit Margin", "value": "-2705.87%", "rating": "E" }, { "name": "Gross Margin", "value": "37.63%", "rating": "B" } ] }, { "name": "Growth", "grade": "A", "indicators": [ { "name": "Revenue YoY", "value": "958.11%", "rating": "A" }, { "name": "Net Profit YoY", "value": "-230.20%", "rating": "E" }, { "name": "Total Assets YoY", "value": "133.61%", "rating": "A" }, { "name": "Net Assets YoY", "value": "247.87%", "rating": "A" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "-3.06%", "rating": "D" }, { "name": "OCF YoY", "value": "958.11%", "rating": "A" } ] }, { "name": "Operating", "grade": "E", "indicators": [ { "name": "Turnover", "value": "0.09", "rating": "E" } ] }, { "name": "Security", "grade": "A", "indicators": [ { "name": "Gearing Ratio", "value": "22.16%", "rating": "A" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B | | 02 | Waystar (US.WAY) | C | A | D | B | B | B | | 03 | Doximity (US.DOCS) | A | B | C | A | C | B | | 04 | Phreesia (US.PHR) | C | B | A | B | D | B | | 05 | 健康流科技 (US.HSTM) | B | C | B | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.39 | 14/42 | - | - | - | | PB | 1.03 | 11/42 | 7.80 | 3.08 | 1.81 | | PS (TTM) | 12.67 | 33/42 | 322.86 | 92.70 | 27.21 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/AIFF.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/AIFF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/AIFF.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.